
    
      This study consists of the following Periods:

        -  Initial Treatment Period from Week 0 to Week 16

        -  Maintenance Treatment Period from Week 16 to Week 48

        -  Open-label Extension Treatment Period (96 weeks)

        -  Safety Follow-Up (10 weeks)
    
  